or Try an Advanced Search...

    Technical Analysis for MTEM - Molecular Templates, Inc.

    Grade Last Price % Change Price Change
    F 1.40 -3.45% -0.05
    MTEM closed down 2.68 percent on Wednesday, May 15, 2024, on 62 percent of normal volume.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical MTEM trend table...
    Date Alert Name Type % Chg
    180 Bearish Setup Bearish Swing Setup -3.45%
    New Downtrend Bearish -6.04%
    Jack-in-the-Box Bearish Bearish Swing Setup -6.04%
    Earnings Movers Other -6.04%
    Inside Day Range Contraction -6.04%
    Gapped Down Weakness -6.04%
    Lower Bollinger Band Touch Weakness -6.04%
    New 52 Week Closing Low Bearish 0.00%
    Expansion Breakdown Bearish Swing Setup 0.00%
    New 52 Week Low Weakness 0.00%
    Older End-of-Day Signals for MTEM ...

       Recent Intraday Alerts

    Alert Time
    Down 3% about 2 hours ago
    Bearish 180 Entry about 2 hours ago
    Fell Below Previous Day's Low about 2 hours ago
    Down 2 % about 2 hours ago
    Down 1% about 2 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    MTEM Chart by TradingView
    Basic chart:

    Profile

    Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of immunotoxins called engineered toxin bodies for the treatment of cancer and other serious diseases. It develops MT-3724, a lead drug candidate that is in a Phase 1 clinical trial in heavily pre-treated non-Hodgkin's lymphoma patients; MT-4019, a preclinical drug candidate targeting CD38; and evofosfamide, an investigational hypoxia-activated prodrug of a bis-alkylating agent that is preferentially activated under severe hypoxic tumor conditions, a feature of many solid tumors. The company is headquartered in Austin, Texas.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Cancer Solid Tumors Cancer Treatment Treatment Of Cancer Oncology Chemical Elements Lymphoma Oxygen Toxins Prodrugs Evofosfamide Prodrug Nitrogen Mustards

    Is MTEM a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 9 Molecular Templates Presents Interim Data from MT-6402 Phase I Study in Patients with PD-L1+ Solid Tumors at the 2024 American Association for Cancer Research (AACR) Annual Meeting; Monotherapy Activity in Checkpoint-Experienced Head and Neck Cancer Pa...
    Mar 29 Molecular Templates GAAP EPS of -$0.73, revenue of $7.02M
    Mar 29 Molecular Templates, Inc. Reports Fourth Quarter 2023 Financial Results and Business Update
    Mar 28 Molecular Templates announces $9.5M private placement offering
    Mar 28 Molecular Templates Announces $9.5 Million Private Placement Offering and Agreement to Amend Second Tranche of July 2023 Purchase Agreement
    Mar 19 Top 5 Health Care Stocks Which Could Rescue Your Portfolio In March
    Feb 8 Molecular Templates to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference
    See more MTEM news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 9.45
    52 Week Low 1.27
    Average Volume 90,284
    200-Day Moving Average 4.67
    50-Day Moving Average 1.98
    20-Day Moving Average 1.58
    10-Day Moving Average 1.56
    Average True Range 0.19
    RSI (14) 35.48
    ADX 25.72
    +DI 12.66
    -DI 21.82
    Chandelier Exit (Long, 3 ATRs) 1.28
    Chandelier Exit (Short, 3 ATRs) 1.83
    Upper Bollinger Bands 1.77
    Lower Bollinger Band 1.39
    Percent B (%b) 0.16
    BandWidth 24.29
    MACD Line -0.15
    MACD Signal Line -0.16
    MACD Histogram 0.0149
    Fundamentals Value
    Market Cap 7.79 Million
    Num Shares 5.37 Million
    EPS -6.92
    Price-to-Earnings (P/E) Ratio -0.21
    Price-to-Sales 0.36
    Price-to-Book 2.77
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.70
    Resistance 3 (R3) 1.72 1.65 1.66
    Resistance 2 (R2) 1.65 1.58 1.64 1.65
    Resistance 1 (R1) 1.55 1.54 1.51 1.53 1.63
    Pivot Point 1.48 1.48 1.46 1.47 1.48
    Support 1 (S1) 1.38 1.42 1.35 1.37 1.27
    Support 2 (S2) 1.31 1.37 1.30 1.25
    Support 3 (S3) 1.21 1.31 1.24
    Support 4 (S4) 1.20